Biobanks operate at the intersection of personalized medicine, big data, and artificial intelligence in modern healthcare. Organizations like the Cooperative Human Tissue Network (CHTN) are uniquely positioned to advance medical research by providing high-quality, well-characterized biospecimens essential for training and validating AI models for clinical use. The management of these valuable resources presents complex challenges spanning data governance, system interoperability, and ethical considerations in human tissue collection and utilization.